J. L. Bainbridge & Co., Inc. Bristol Myers Squibb CO Call Options Transaction History

J. L. Bainbridge & Co., Inc.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $1.07 Million - $1.25 Million	-20,000 Reduced 44.44%	25,000 $1.56 Million
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $1.55 Million - $1.69 Million	-25,000 Reduced 35.71%	45,000 $3.01 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $1.44 Million - $1.64 Million	25,000 Added 55.56%	70,000 $4.34 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $574,300 - $636,400	-10,000 Reduced 18.18%	45,000 $2.71 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $2.47 Million - $2.88 Million	45,000 Added 450.0%	55,000 $3.23 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $492,100 - $641,900	10,000 New	10,000 $642,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.